70 related articles for article (PubMed ID: 20032046)
1. Siglec-7 mediates nonapoptotic cell death independently of its immunoreceptor tyrosine-based inhibitory motifs in monocytic cell line U937.
Mitsuki M; Nara K; Yamaji T; Enomoto A; Kanno M; Yamaguchi Y; Yamada A; Waguri S; Hashimoto Y
Glycobiology; 2010 Mar; 20(3):395-402. PubMed ID: 20032046
[TBL] [Abstract][Full Text] [Related]
2. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
3. Cloning and molecular characterization of two splice variants of a new putative member of the Siglec-3-like subgroup of Siglecs.
Foussias G; Taylor SM; Yousef GM; Tropak MB; Ordon MH; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):887-99. PubMed ID: 11409877
[TBL] [Abstract][Full Text] [Related]
4. Probing the cis interactions of the inhibitory receptor Siglec-7 with alpha2,8-disialylated ligands on natural killer cells and other leukocytes using glycan-specific antibodies and by analysis of alpha2,8-sialyltransferase gene expression.
Avril T; North SJ; Haslam SM; Willison HJ; Crocker PR
J Leukoc Biol; 2006 Oct; 80(4):787-96. PubMed ID: 16857734
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of leucocyte functions by CD33-related siglecs.
Avril T; Attrill H; Zhang J; Raper A; Crocker PR
Biochem Soc Trans; 2006 Dec; 34(Pt 6):1024-7. PubMed ID: 17073742
[TBL] [Abstract][Full Text] [Related]
6. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells.
Li N; Zhang W; Wan T; Zhang J; Chen T; Yu Y; Wang J; Cao X
J Biol Chem; 2001 Jul; 276(30):28106-12. PubMed ID: 11358961
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants.
Yousef GM; Ordon MH; Foussias G; Diamandis EP
Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes.
Nicoll G; Ni J; Liu D; Klenerman P; Munday J; Dubock S; Mattei MG; Crocker PR
J Biol Chem; 1999 Nov; 274(48):34089-95. PubMed ID: 10567377
[TBL] [Abstract][Full Text] [Related]
9. Human-specific expression of Siglec-6 in the placenta.
Brinkman-Van der Linden EC; Hurtado-Ziola N; Hayakawa T; Wiggleton L; Benirschke K; Varki A; Varki N
Glycobiology; 2007 Sep; 17(9):922-31. PubMed ID: 17580316
[TBL] [Abstract][Full Text] [Related]
10. Different patterns of Siglec-9-mediated neutrophil death responses in septic shock.
von Gunten S; Jakob SM; Geering B; Takala J; Simon HU
Shock; 2009 Oct; 32(4):386-92. PubMed ID: 19295491
[TBL] [Abstract][Full Text] [Related]
11. Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
Varchetta S; Brunetta E; Roberto A; Mikulak J; Hudspeth KL; Mondelli MU; Mavilio D
PLoS One; 2012; 7(9):e45821. PubMed ID: 23029261
[TBL] [Abstract][Full Text] [Related]
12. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
[TBL] [Abstract][Full Text] [Related]
13. Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs.
Ando M; Tu W; Nishijima K; Iijima S
Biochem Biophys Res Commun; 2008 May; 369(3):878-83. PubMed ID: 18325328
[TBL] [Abstract][Full Text] [Related]
14. Siglec-6 Signaling Uses Src Kinase Tyrosine Phosphorylation and SHP-2 Recruitment.
Stefanski AL; Renecle MD; Kramer A; Sehgal S; Narasimhan P; Rumer KK; Winn VD
Cells; 2022 Oct; 11(21):. PubMed ID: 36359823
[TBL] [Abstract][Full Text] [Related]
15. Deletion polymorphism of SIGLEC14 and its functional implications.
Yamanaka M; Kato Y; Angata T; Narimatsu H
Glycobiology; 2009 Aug; 19(8):841-6. PubMed ID: 19369701
[TBL] [Abstract][Full Text] [Related]
16. Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation.
Ishida A; Ohta M; Toda M; Murata T; Usui T; Akita K; Inoue M; Nakada H
Proteomics; 2008 Aug; 8(16):3342-9. PubMed ID: 18690650
[TBL] [Abstract][Full Text] [Related]
17. Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms.
Nicoll G; Avril T; Lock K; Furukawa K; Bovin N; Crocker PR
Eur J Immunol; 2003 Jun; 33(6):1642-8. PubMed ID: 12778482
[TBL] [Abstract][Full Text] [Related]
18. Myeloid precursors and acute myeloid leukemia cells express multiple CD33-related Siglecs.
Nguyen DH; Ball ED; Varki A
Exp Hematol; 2006 Jun; 34(6):728-35. PubMed ID: 16728277
[TBL] [Abstract][Full Text] [Related]
19. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
Daëron M; Jaeger S; Du Pasquier L; Vivier E
Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
[TBL] [Abstract][Full Text] [Related]
20. Human Siglec-5: tissue distribution, novel isoforms and domain specificities for sialic acid-dependent ligand interactions.
Connolly NP; Jones M; Watt SM
Br J Haematol; 2002 Oct; 119(1):221-38. PubMed ID: 12358929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
